Scavenging of Alzheimer's amyloid beta-protein by microglia in culture

被引:0
|
作者
Ard, MD
Cole, GM
Wei, J
Mehrle, AP
Fratkin, JD
机构
[1] UNIV MISSISSIPPI,MED CTR,DEPT PATHOL,JACKSON,MS 39216
[2] UNIV CALIF LOS ANGELES,DEPT MED,LOS ANGELES,CA 90024
[3] VET ADM MED CTR,CTR GERIATR RES EDUC & CLIN,SEPULVEDA,CA 91343
关键词
amyloid beta-protein; A beta(1-42); central nervous system phagocytes; microglia;
D O I
10.1002/(SICI)1097-4547(19960115)43:2<190::AID-JNR7>3.0.CO;2-B
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Deposits of amyloid beta-protein (A beta) form the cores of the pathological plaques which characterize Alzheimer's disease. The mechanism of formation of the deposits is unknown; one possibility is failure of a clearance mechanism that would normally remove the protein from brain parenchyma. This study has investigated the capacity of the central nervous system (CNS) phagocytes, microglia cells, to clear exogenous A beta(1-42) from their environment, Cultured microglia from adult rat CNS have a high capacity to remove A beta from serum-free medium, shown by immunoblotting experiments, A beta from incubation medium was attached to the cell surface and could be identified by immunocytochemistry at the light or electron microscopic (EM) level; by EM, A beta also appeared in phagosome-like intracellular vesicles. Light microscopic immunocytochemistry combined with computer-assisted image analysis showed that cells accumulated A beta within 24 hr, from culture medium containing from 1 to 20 mu g/ml A beta. Microglial accumulation of A beta was substantially reduced in the presence of fetal bovine serum. Addition of the protease inhibitor leupeptin to incubation medium with serum resulted in accumulation of A beta in a membrane-bound intracellular compartment, but not at the cell surface, The increase in intracellular accumulation in the presence of the protease inhibitor indicates a microglial capacity for intracellular degradation of A beta in the absence of inhibition, The change from predominantly cell-surface accumulation in serum-free medium to predominantly intracellular accumulation with serum may be explained by the presence in serum of carrier proteins that complex with A beta and target it to cell surface receptors capable of stimulating endocytosis. Microglia were also cultured on unfixed cryostat sections of human brain tissue containing Alzheimer's plaques. Very little A beta from the tissue was accumulated by the cells, although cultured microglia were found in direct contact with anti-A beta immunopositive plaques. Possibly A beta in tissue sections was complexed with other proteins which either inhibited its uptake by microglia or enhanced its proteolysis, preventing cellular accumulation of immunostainable A beta. The results indicate that cultured microglia effectively remove A beta from tissue culture medium and from the surface of the dish and concentrate monomer and aggregates of A beta either on the cell surface or intracellularly. This process may be modified by proteins present in Alzheimer's brain sections. (C) 1996 Wiley-Liss, Inc.
引用
收藏
页码:190 / 202
页数:13
相关论文
共 50 条
  • [21] Amyloid beta-protein induces the cerebrovascular cellular pathology of Alzheimer's disease and related disorders
    VanNostrand, WE
    DavisSalinas, J
    SaporitoIrwin, SM
    NEUROBIOLOGY OF ALZHEIMER'S DISEASE, 1996, 777 : 297 - 302
  • [22] ALZHEIMER-DISEASE AND THE PRION DISORDERS AMYLOID BETA-PROTEIN AND PRION PROTEIN AMYLOIDOSES
    PRICE, DL
    BORCHELT, DR
    SISODIA, SS
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (14) : 6381 - 6384
  • [23] AMYLOID BETA-PROTEIN PRECURSOR IS A MITOGEN
    SCHUBERT, D
    COLE, G
    SAITOH, T
    OLTERSDORF, T
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 162 (01) : 83 - 88
  • [24] Fractionation of amyloid beta-protein (A beta) in Alzheimer's disease and Down's syndrome brains - Presence of membrane-bound A beta
    Yanagisawa, K
    AsamiOdaka, A
    Suzuki, N
    Ihara, Y
    PHARMACOLOGICAL INTERVENTION IN AGING AND AGE-ASSOCIATED DISORDERS: PROCEEDINGS OF THE SIXTH CONGRESS OF THE INTERNATIONAL ASSOCIATION OF BIOMEDICAL GERONTOLOGY, 1996, 786 : 184 - 194
  • [25] INTRACELLULAR ACCUMULATION AND RESISTANCE TO DEGRADATION OF THE ALZHEIMER AMYLOID A4/BETA-PROTEIN
    KNAUER, MF
    SOREGHAN, B
    BURDICK, D
    KOSMOSKI, J
    GLABE, CG
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (16) : 7437 - 7441
  • [26] Amyloid beta-protein and lipid metabolism
    Zinser, Eva G.
    Hartmann, Tobias
    Grimm, Marcus O. W.
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2007, 1768 (08): : 1991 - 2001
  • [27] DEPOSITION OF AMYLOID BETA-PROTEIN IN NON-ALZHEIMER DEMENTIAS - EVIDENCE FOR A NEURONAL ORIGIN OF PARENCHYMAL DEPOSITS OF BETA-PROTEIN IN NEURODEGENERATIVE DISEASE
    MANN, DMA
    JONES, D
    SOUTH, PW
    SNOWDEN, JS
    NEARY, D
    ACTA NEUROPATHOLOGICA, 1992, 83 (04) : 415 - 419
  • [28] Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor
    Paresce, DM
    Ghosh, RN
    Maxfield, FR
    NEURON, 1996, 17 (03) : 553 - 565
  • [29] Aggregation of amyloid beta-protein as function of age and apolipoprotein E in normal and Alzheimer's serum.
    Chauhan, A
    Pirttila, T
    Chauhan, VPS
    Mehta, P
    Wisniewski, HM
    FASEB JOURNAL, 1997, 11 (03): : 3637 - 3637
  • [30] Genetic associations with the pattern of amyloid beta-protein pathology point to subtypes of sporadic Alzheimer's disease
    Dietmar, R. Th
    Papassotiropoulos, A.
    Saido, T. C.
    Griffin, W. S. T.
    Mrak, R. E.
    Koelsch, H.
    Tredici, K. D.
    Johannes, A.
    Ghebremedhin, E.
    BRAIN PATHOLOGY, 2010, 20 : 20 - 20